Evidence map›Paper›PMID 42464712›Full record

ArticleEuropean journal of neurology2026

Corticospinal Subfiber Neurite Density Index Detects Upper Motor Neuron Degeneration in Prediagnostic Patients With Sporadic Amyotrophic Lateral Sclerosis.

Ninglu Gao, Bo Cui, Yan Yun, Wenfei Yu, Xianlei Gao, Xiaohan Sun, Kai Shao, Pengfei Lin, Fuchen Liu, Wei Li and 5 more

Abstract read
In one paragraph

Article in European journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ninglu GaoDepartment of Neurology, Research Institute of Neuromuscular and Neurodegenerative Diseases, Shandong Provincial Key Laboratory of Mitochondrial Medicine and Rare Diseases, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Bo CuiDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Yan YunDepartment of Radiology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Wenfei YuDepartment of Neurology, Research Institute of Neuromuscular and Neurodegenerative Diseases, Shandong Provincial Key Laboratory of Mitochondrial Medicine and Rare Diseases, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Xianlei GaoDepartment of Orthopaedic Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Xiaohan SunDepartment of Neurology, Research Institute of Neuromuscular and Neurodegenerative Diseases, Shandong Provincial Key Laboratory of Mitochondrial Medicine and Rare Diseases, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Kai ShaoLaboratory of Cerebrospinal Fluid Cytology and Neuroimmunology, Department of Central Laboratory, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, China.ORCID https://orcid.org/0000-0003-1563-5722
Pengfei LinDepartment of Neurology, Research Institute of Neuromuscular and Neurodegenerative Diseases, Shandong Provincial Key Laboratory of Mitochondrial Medicine and Rare Diseases, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Fuchen LiuDepartment of Neurology, Research Institute of Neuromuscular and Neurodegenerative Diseases, Shandong Provincial Key Laboratory of Mitochondrial Medicine and Rare Diseases, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.ORCID https://orcid.org/0000-0002-8882-4172
Wei LiDepartment of Neurology, Research Institute of Neuromuscular and Neurodegenerative Diseases, Shandong Provincial Key Laboratory of Mitochondrial Medicine and Rare Diseases, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Yuying ZhaoDepartment of Neurology, Research Institute of Neuromuscular and Neurodegenerative Diseases, Shandong Provincial Key Laboratory of Mitochondrial Medicine and Rare Diseases, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Dexin YuDepartment of Radiology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.ORCID https://orcid.org/0000-0002-3430-4817
Chuanzhu YanDepartment of Neurology, Research Institute of Neuromuscular and Neurodegenerative Diseases, Shandong Provincial Key Laboratory of Mitochondrial Medicine and Rare Diseases, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Shuangwu LiuDepartment of Neurology, Research Institute of Neuromuscular and Neurodegenerative Diseases, Shandong Provincial Key Laboratory of Mitochondrial Medicine and Rare Diseases, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Jianwei LouDepartment of Neurology, Qilu Hospital, Shandong University, Jinan, China.ORCID https://orcid.org/0009-0004-0807-8416

Funding

National Natural Science Foundation of China 82471429Natural Science Foundation of Shandong Province ZR2024MH013the Key Research and Development Program of Shandong Province, China 2025CXPT133the Yantu Neuroscience Specialized Research Fund Project Z-2017-24-2509
6 · The paper itself

Abstract

backgroundUsing multi-shell diffusion MRI, we aimed to identify whether corticospinal tract (CST) subfiber damage can be detected in prediagnostic amyotrophic lateral sclerosis (ALS) patients. We also explored whether the combination of serum neurofilament light chain (NfL) levels and CST subfiber abnormalities may provide better diagnostic performance in differentiating prediagnostic ALS patients from disease controls (DCs) and healthy controls (HCs) than single markers.

methodsIn this retrospective study, prediagnostic ALS was used as an operational term for patients who presented at baseline with chronic progressive limb weakness or bulbar symptoms, had no clinically evident typical UMN signs, and were subsequently confirmed to have sporadic ALS according to the Awaji criteria during longitudinal follow-up. Patients whose final diagnosis was not ALS after follow-up were classified as disease controls. Probabilistic tractography was performed on baseline MRI data to assess CST subfiber damage in 47 ALS patients, 20 DCs, and 51 HCs.

resultsCompared with Controls, ALS patients had significantly lower neurite density index (NDI) values of CST subfibers, particularly those originating from the primary and supplementary motor cortex. The diagnostic performance of the combined model incorporating serum NfL and CST subfiber NDI values in differentiating prediagnostic ALS patients from HCs and DCs was 0.925 and 0.928, respectively, which was better than that of single markers (0.634-0.886 and 0.699-0.856, respectively).

conclusionsOur findings suggest that CST subfibers NDI values are promising neuroimaging markers for detecting in vivo UMN degeneration in prediagnostic ALS. Moreover, combining blood and neuroimaging markers may further improve early diagnostic performance.

Indexed as

Amyotrophic Lateral SclerosisMotor NeuronsNerve DegenerationNeuritesPyramidal TractsAgedDiffusion Magnetic Resonance ImagingDiffusion Tensor ImagingFemaleHumansMaleMiddle AgedNeurofilament ProteinsRetrospective Studiesneurofilament protein LNeurofilament ProteinsALSCST subfiberearly diagnosisNfLNODDI

Identifiers

PMID42464712
PMCPMC13377214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.